| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/26/2009 | CN100532552C Gene sequence of coding perinereis albuhitensis grube cysteine protease inhibitor and its amino acid sequence and application |
| 08/26/2009 | CN100532551C Pig's epidermal growth factor gene and its application |
| 08/26/2009 | CN100532549C Genes and polypeptides relating to human colon cancers |
| 08/26/2009 | CN100532548C Method of increasing yield of human papilloma virus L1 albumen pronucleus expression |
| 08/26/2009 | CN100532394C Method of modifying elastin by atom transition free radical polymerization reaction |
| 08/26/2009 | CN100532393C Method of modifying elastin by initiation transition termination agent |
| 08/26/2009 | CN100532391C Method for extracting and separating bean active polypeptide and its amino-acid sequence |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531794C Compositions and methods for modifying toxic effects of protein compounds |
| 08/25/2009 | US7579530 Inbred maize line PHHCA |
| 08/25/2009 | US7579529 AP2 domain transcription factor ODP2 (ovule development protein 2) and methods of use |
| 08/25/2009 | US7579518 Plants having improved seed yield and expressing a nucleic acid encoding a small subunit ribosomal (S3A) protein and method for making the same |
| 08/25/2009 | US7579515 Use of the present invention will enhance proper timing; if the switch increases ovulation >2.4-fold, oocyte production can be achieved even more efficiently, creating major benefits for the transgenic/cloning industry |
| 08/25/2009 | US7579453 comprehensive collection of single nucleotide polymorphisms (SNPs) in bitter taste receptor (T2R) genes; a portion of these SNPs define biologically relevant difference between different alleles of the bitter taste receptor genes; allelic information is useful in the development of flavoring and enhancer |
| 08/25/2009 | US7579444 coagulants is a drug/polymer conjugates/, contains blood-coagulation factor IX covalently attached through a spacer moiety to a endcapped polyethylene glycol; blood disorders |
| 08/25/2009 | US7579443 Lyases; improved ethanol biosynthesis, stalk and nodal strength |
| 08/25/2009 | US7579441 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo |
| 08/25/2009 | US7579440 Mammalian cytokines; related reagents |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579438 Use of the gene NcSAG4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 08/25/2009 | US7579437 Polypeptides and methods for making the same |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579433 18-Residue dimerized peptide designated PIP [59-67] dimer, having dual inhibitory activity against secretory phospholipase A2 (sPLA2) and matrix metalloproteinases (MMPs); acute pancreatitis; infection; neurodegenerative disease; neuronal excitotoxicity |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579328 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus |
| 08/25/2009 | US7579327 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 08/25/2009 | US7579322 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 08/25/2009 | US7579317 S-sulfonated; for use in oral supplement to cause reduction in oxidative stress, promoting skin health and antiinflammatory effect |
| 08/25/2009 | US7579316 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
| 08/25/2009 | US7579315 Casein peptides for alleviating or preventing aging of skin |
| 08/25/2009 | US7579314 Use of RGD-enriched gelatine-like proteins for inhibition of cancer metastasis |
| 08/25/2009 | US7579182 against tularemia; subcellular protein expressed from Francisella tularensis infected mammal subculture growing in synthetic salts medium of weak acidity |
| 08/25/2009 | US7579175 Aqueous culture product using power source; containing aldolase or synthetase |
| 08/25/2009 | US7579173 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same |
| 08/25/2009 | US7579169 producing a mutant HH polypeptide by transforming isolated host cells with a vector capable of expressing the polypeptide from the nucleic acid sequence; diagnosis, prenatal screening and diagnosis, and therapies of blood disorders |
| 08/25/2009 | US7579168 Human Dickkopf-related nucleic acid molecules |
| 08/25/2009 | US7579166 lysosomal enzyme having a mannose-6-phosphate-containing acidic sugar chain; a labeling marker for transporting into lysosomes; used as a drug effective in treatment of human lysosomal enzyme deficiencies |
| 08/25/2009 | US7579165 Modified by immobilizing with disulfide-containing compound; mass spectrometry; solid phase synthesis |
| 08/25/2009 | US7579161 Assay methods for suppressor of fused modulation of hedgehog signaling |
| 08/25/2009 | US7579160 Cervical Cancer; Using monoclonal antibody comprising immunostimulant domains to diagnose and treat cell proliferative disorders; binding; lung tumor polypeptides, immunogenic portions, polynucleotides that encode such polypeptides, antigen presenting , T cells that are specific; |
| 08/25/2009 | US7579147 Screening for mutant nucleic acids; medical diagnosis |
| 08/25/2009 | US7579142 Methods for purification of bacterial cells and components |
| 08/25/2009 | US7579141 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 08/25/2009 | US7579013 Transdermal drug delivery device having stratum corneum-piercing microprojections; pH stability and solubility when dried; |
| 08/25/2009 | US7579011 isolated polypeptide use in vaccines against A. salmonicida infections such as fish disease furunculosis |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | US7578999 Antibodies specific for sclerostin |
| 08/25/2009 | US7578998 Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use |
| 08/25/2009 | CA2395539C Soluble interleukin-20 receptor |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2372456C Viral infection inhibitor targeting integrase n-terminal domain |
| 08/25/2009 | CA2368217C Bacterial cell component-unresponsive model mouse |
| 08/25/2009 | CA2309600C Low-temperature inducible expression vector |
| 08/25/2009 | CA2099541C Cyclic adhesion inhibitors |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/20/2009 | WO2009102978A2 Ac field induced biomolecule crystallization and hydration cage disruption |
| 08/20/2009 | WO2009102971A1 Zea mays aba signaling genes and methods of use |
| 08/20/2009 | WO2009102840A1 Prostate secretory protein and its domains as frameworks for novel binding molecules |
| 08/20/2009 | WO2009102792A2 Human collagen products and methods for producing human collagen products |
| 08/20/2009 | WO2009102569A2 Cell lines and methods for making and using them |
| 08/20/2009 | WO2009102421A2 Targeted therapeutics based on engineered proteins that bind egfr |
| 08/20/2009 | WO2009102357A2 Hiv-1 envelope glycoprotein oligomer and methods of use |
| 08/20/2009 | WO2009102229A1 Lipid-protein raft complex made of the influenza a virus shell for anti-influenza vaccines and a method for the isolation thereof, a method for producing virus-like particles from such complexes |
| 08/20/2009 | WO2009102008A1 Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity |
| 08/20/2009 | WO2009101737A1 Protein expression vector tagged with peptide having methionine residue |
| 08/20/2009 | WO2009101403A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 08/20/2009 | WO2009101383A1 Mutant proteins and methods for selecting them |
| 08/20/2009 | WO2009101344A1 Combination of a light ray with a cytochrome c oxydase substrate particularly for improving the appearance of the skin and/or hair |
| 08/20/2009 | WO2009101207A1 Cd4+ t-cells with cytolytic properties |
| 08/20/2009 | WO2009101206A2 Strategies to prevent and/or treat immune responses to soluble allofactors |
| 08/20/2009 | WO2009101205A2 Immunogenic control of tumours and tumour cells |
| 08/20/2009 | WO2009101204A2 Elimination of immune responses to viral vectors |
| 08/20/2009 | WO2009101181A2 Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells |
| 08/20/2009 | WO2009101134A1 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 08/20/2009 | WO2009100934A1 Identification of a novel cysteine-rich cell penetrating peptide |
| 08/20/2009 | WO2009100893A1 Neuroprotective peptides |
| 08/20/2009 | WO2009100724A1 Novel peptide derived from ncam (bcl) |
| 08/20/2009 | WO2009100505A1 Immunogenic peptides and their use in transplantation |
| 08/20/2009 | WO2009100489A1 Crystal structure of pfa-mi and the pfa-mi co4 complex |
| 08/20/2009 | WO2009081069A3 Polyclonal antibody directed against the elastin binding protein and method for obtaining same |
| 08/20/2009 | WO2009079775A9 Composition for supporting heat shock protein function comprising glutamine |
| 08/20/2009 | WO2009077618A3 A host cell deficient for murf1 and murf2 |
| 08/20/2009 | WO2009073104A3 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 08/20/2009 | WO2009066967A3 Microrna antisense pnas, compositions comprising the same, and methods for using and evaluating the same |
| 08/20/2009 | WO2009059078A3 Method of genetically altering and producing allergy free cats |
| 08/20/2009 | WO2009029342A3 B7-dc variants |
| 08/20/2009 | US20090210966 rice blast susceptibility gene pi21, resistance gene pi21 and uses thereof |
| 08/20/2009 | US20090210956 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 08/20/2009 | US20090209731 Heteromeric taste receptors |
| 08/20/2009 | US20090209730 Method for gene transfer into target cells with retrovirus |
| 08/20/2009 | US20090209729 Recombinant chemokine-antigen vaccine |
| 08/20/2009 | US20090209630 Vectors carrying coding sequences for angiogenic agents such as Del-1or VEGF formulated with poloxamers to improve bioavailability; avoids problems with toxicity inherent to existing delivery technologies; treating ischemia in a muscle, kidney or brain tissue |
| 08/20/2009 | US20090209551 Essential tremor diagnostic and treatment |
| 08/20/2009 | US20090209470 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 08/20/2009 | US20090209466 Peptides with anti-proliferative activity |
| 08/20/2009 | US20090209464 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins |
| 08/20/2009 | US20090209463 Hgf Precursor Protein Variant and Active Protein Thereof |
| 08/20/2009 | US20090209460 Compositions and methods for treating obesity and related metabolic disorders |